Search

Displaying results 7271 - 7280 of 10000 in total
  1. Drug

    Furacrinic acid

    go.drugbank.com/drugs/DB21223
    Experimental

    Furacrinic acid is a small molecule drug. Furacrinic acid has a monoisotopic molecular weight of 258.09 Da.

  2. Drug

    Xantofyl palmitate

    go.drugbank.com/drugs/DB21273
    Experimental

    Xantofyl palmitate is a small molecule drug. Xantofyl palmitate has a monoisotopic molecular weight of 1044.89 Da.

  3. Drug

    Cromoglicate lisetil

    go.drugbank.com/drugs/DB21297
    Experimental

    Cromoglicate lisetil is a small molecule drug. Cromoglicate lisetil has a monoisotopic molecular weight of 652.23 Da.

  4. Drug

    Iobutoic acid

    go.drugbank.com/drugs/DB21443
    Experimental

    Iobutoic acid is a small molecule drug. Iobutoic acid has a monoisotopic molecular weight of 670.82 Da.

  5. Drug

    Dipyridamole

    go.drugbank.com/drugs/DB00975
    ApprovedInvestigational

    A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin.

    Products: Dipyridamole for Injection
  6. Drug

    Emricasan

    go.drugbank.com/drugs/DB05408
    Investigational

    It is developed by Pfizer and made in such a way that it protects liver cells from excessive apoptosis.

  7. Drug

    Recanaclotide

    go.drugbank.com/drugs/DB15417
    Investigational

    Recanaclotide is under investigation in clinical trial NCT01712412 (Phase 2a Study of IW-9179 to Treat Functional Dyspepsia).

  8. Drug

    Acipimox

    go.drugbank.com/drugs/DB09055
    ApprovedInvestigational

    Acipimox is a niacin derivative used as a hypolipidemic agent. … Acipimox inhibits the production of triglycerides by the liver and the secretion of VLDL, which leads indirectly to a modest reduction in LDL and increase in HDL.

  9. Drug

    Diflunisal

    go.drugbank.com/drugs/DB00861
    Approved

    Diflunisal, a salicylate derivative, is a nonsteroidal anti-inflammatory agent (NSAIA) with pharmacologic actions similar to other prototypical NSAIAs.

  10. Drug

    Biperiden

    go.drugbank.com/drugs/DB00810
    ApprovedInvestigationalWithdrawn

    A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism.